136 studies found for:    Open Studies | "Thyroid Neoplasms"
Show Display Options
Rank Status Study
21 Unknown  Influence of Thyroid Hormones on the Woundhealing Process
Conditions: Thyroid Neoplasms;   Thyroid Carcinoma
Intervention: Procedure: blood sampling
22 Unknown  Pemetrexed + Paclitaxel in Patients With Recurrent/Advanced Thyroid Cancer
Condition: Thyroid Cancer
Intervention: Drug: pemetrexed + paclitaxel
23 Recruiting Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer
Conditions: Poorly Differentiated Thyroid Gland Carcinoma;   Recurrent Thyroid Gland Carcinoma;   Stage IVA Thyroid Gland Follicular Carcinoma;   Stage IVA Thyroid Gland Papillary Carcinoma;   Stage IVB Thyroid Gland Follicular Carcinoma;   Stage IVB Thyroid Gland Papillary Carcinoma;   Stage IVC Thyroid Gland Follicular Carcinoma;   Stage IVC Thyroid Gland Papillary Carcinoma
Interventions: Procedure: Computed Tomography;   Radiation: Iodine I 124;   Radiation: Iodine I-131;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Procedure: Positron Emission Tomography;   Drug: Trametinib
24 Recruiting Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer
Conditions: Poorly Differentiated Thyroid Gland Carcinoma;   Recurrent Thyroid Gland Carcinoma;   Stage IVA Thyroid Gland Follicular Carcinoma;   Stage IVA Thyroid Gland Papillary Carcinoma;   Stage IVB Thyroid Gland Follicular Carcinoma;   Stage IVB Thyroid Gland Papillary Carcinoma;   Stage IVC Thyroid Gland Follicular Carcinoma;   Stage IVC Thyroid Gland Papillary Carcinoma
Interventions: Other: Placebo;   Drug: Selumetinib;   Radiation: Iodine I-131;   Other: Laboratory Biomarker Analysis
25 Recruiting A Phase 2 Study of GI-6207 in Patients With Recurrent Medullary Thyroid Cancer
Condition: Medullary Thyroid Cancer
Intervention: Biological: GI-6207
26 Recruiting A Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer
Condition: Medullary Thyroid Cancer
Interventions: Drug: Cabozantinib (XL184) 140 mg;   Drug: Cabozantinib (XL184) 60 mg;   Drug: Placebo tablet;   Drug: Placebo capsule
27 Unknown  Diagnosing Thyroid Cancer Using a Blood Test
Condition: Differentiated Thyroid Cancer
Intervention:
28 Recruiting Study of External Beam Radiotherapy to Thyroid Carcinoma
Condition: Thyroid Cancer
Intervention: Radiation: External Beam Radiotherapy
29 Recruiting Determination of Pronostics Factors for Advanced Thyroid Carcinoma (pT3 pT4 or M1 at Diagnosis)
Condition: Thyroid Cancer
Intervention: Other: follow up visit
30 Unknown  Feasibility of Endoscopic Thyroidectomy for Thyroid Carcinoma
Condition: Thyroid Carcinoma
Intervention: Procedure: thyroidectomy
31 Unknown  Radioiodine Dosimetry Protocol for Thyroid Cancer Metastases
Conditions: Thyroid Carcinoma;   Metastatic Sites Lung Bone Nodal
Intervention: Other: SPECT scan
32 Recruiting The Use of Candy and Honey in Decreasing Salivary Gland Damage Following Radioiodine Therapy for Thyroid Cancer
Condition: Thyroid Cancer
Intervention: Dietary Supplement: thymus honey mouthwash
33 Recruiting Ceritinib (LDK378) in Mutation and Oncogene Directed Therapy in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer
Conditions: Metastatic Anaplastic/Undifferentiated Thyroid Cancer;   Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer
Intervention: Drug: Ceritinib
34 Recruiting Developing and Implementing an Interdisciplinary Team-Based Care Approach (ITCA-ThyCa) for Thyroid Cancer Patients
Condition: Thyroid Cancer
Interventions: Other: Interdisciplinary Team-Based Approach;   Other: Usual Care Control
35 Recruiting The Effect of Coffee on the Absorption of Thyroid Hormone in Patients With Thyroid Carcinoma
Conditions: Thyroid Carcinoma;   Hypothyroidism
Interventions: Other: Black Coffee;   Other: Coffee with Milk;   Other: Black Tea;   Other: Water
36 Recruiting A Trial of Pasireotide and Everolimus in Adult Patients With Radioiodine-Refractory Differentiated and Medullary Thyroid Cancer
Condition: Thyroid Cancer
Interventions: Drug: Everolimus;   Drug: Pasireotide;   Drug: Everolimus and Pasireotide
37 Unknown  BRAF V600E Mutations In Papillary Thyroid Carcinoma
Condition: Papillary Thyroid Carcinoma
Intervention: Genetic: BRAF V600E POSITIVITY
38 Recruiting Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma
Condition: Thyroid Carcinoma
Interventions: Drug: Continuous pazopanib (Arm A);   Drug: Intermittent pazopanib (Arm B)
39 Recruiting Prospective, Non-interventional, Post-authorization Safety Study That Includes All Patients Diagnosed as Unresectable Differentiated Thyroid Carcinoma and Treated With Sorafenib
Condition: Thyroid Carcinoma
Intervention: Drug: Sorafenib (Nexavar, BAY43-9006)
40 Unknown  Diagnostic Utility of [18F]-FDG-PET/CT and [124I]-PET/CT for Detection of Recurrence in Differentiated Thyroid Carcinoma
Conditions: Thyroid Cancer;   Recurrence
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years